Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Lantheus Medical Imaging, Inc. the company’s novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta. Read more.